Literature DB >> 2621019

A population-based case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease?

E B Machado1, S E Gabriel, C M Beard, C J Michet, W M O'Fallon, D J Ballard.   

Abstract

The first population-based incident case-control study of temporal arteritis (TA) in the US was conducted using the unique data resources of the Rochester Epidemiology Project. During the period 1950-1985, 88 newly diagnosed cases of biopsy-proven TA were identified among residents of Olmsted County, Minnesota. Cases were each matched to four Olmsted County community controls on age, sex and duration of community medical record. Odds ratios (OR) were calculated for marital status, education, Quetelet index, pregnancy, age at menopause, thyroid disease, diabetes, smoking, hypertension, angina, myocardial infarction, peripheral vascular disease, and stroke. Multivariable conditional logistic regression analysis identified statistically significant adjusted OR for smoking (2.3, 95% CI = 1.3-4.1). Elevated ORs which were not statistically significant were noted for angina, myocardial infarction, and peripheral vascular disease. These data suggest that TA and arteriosclerosis may share a common causal pathway. Alternatively, histopathological misclassification of temporal artery biopsies may have resulted in the observed association. Due to the limited power of this population-based study, multicentre collaboration should be encouraged to more precisely define the epidemiology of TA.

Entities:  

Mesh:

Year:  1989        PMID: 2621019     DOI: 10.1093/ije/18.4.836

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  14 in total

1.  Lower body mass index is associated with a higher risk of giant cell arteritis: a systematic review and meta-analysis.

Authors:  Patompong Ungprasert; Charat Thongprayoon; Kenneth J Warrington
Journal:  Ann Transl Med       Date:  2015-09

2.  Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis.

Authors:  K Larsson; D Mellström; E Nordborg; C Nordborg; A Odén; E Nordborg
Journal:  Ann Rheum Dis       Date:  2005-08-26       Impact factor: 19.103

3.  Giant cell arteritis and cardiovascular disease in older adults.

Authors:  J G Ray; M M Mamdani; W H Geerts
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

4.  Cardiovascular risk factors associated with polymyalgia rheumatica and giant cell arteritis in a prospective cohort: EPIC-Norfolk Study.

Authors:  Max Yates; Robert Luben; Shabina Hayat; Sarah L Mackie; Richard A Watts; Kay-Tee Khaw; Nick J Wareham; Alex J MacGregor
Journal:  Rheumatology (Oxford)       Date:  2020-02-01       Impact factor: 7.580

5.  Statin use in giant cell arteritis: a retrospective study.

Authors:  Jean Schmidt; Tanaz A Kermani; Francesco Muratore; Cynthia S Crowson; Eric L Matteson; Kenneth J Warrington
Journal:  J Rheumatol       Date:  2013-04-01       Impact factor: 4.666

Review 6.  Clinical features of polymyalgia rheumatica and giant cell arteritis.

Authors:  Carlo Salvarani; Nicolò Pipitone; Annibale Versari; Gene G Hunder
Journal:  Nat Rev Rheumatol       Date:  2012-07-24       Impact factor: 20.543

7.  Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study.

Authors:  Cristian Labarca; Matthew J Koster; Cynthia S Crowson; Ashima Makol; Steven R Ytterberg; Eric L Matteson; Kenneth J Warrington
Journal:  Rheumatology (Oxford)       Date:  2015-09-18       Impact factor: 7.580

8.  Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis.

Authors:  Tanaz A Kermani; Kenneth J Warrington; Cynthia S Crowson; Steven R Ytterberg; Gene G Hunder; Sherine E Gabriel; Eric L Matteson
Journal:  Ann Rheum Dis       Date:  2012-12-19       Impact factor: 19.103

9.  Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis.

Authors:  M Lopez-Hoyos; M J Bartolome-Pacheco; R Blanco; V Rodriguez-Valverde; V M Martinez-Taboada
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

Review 10.  [Giant cell arteritis (temporal arteritis). Pathophysiology, immunology].

Authors:  A D Wagner
Journal:  Ophthalmologe       Date:  2006-04       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.